Investments - Investments in Associates and Joint Ventures (Details)
|
1 Months Ended |
3 Months Ended |
9 Months Ended |
12 Months Ended |
|
|
Aug. 31, 2025
BRL (R$)
|
Sep. 30, 2025
BRL (R$)
|
Sep. 30, 2024
BRL (R$)
|
Sep. 30, 2025
BRL (R$)
|
Sep. 30, 2025
BRL (R$)
€ / shares
|
Sep. 30, 2024
BRL (R$)
|
Sep. 30, 2024
BRL (R$)
€ / shares
|
Dec. 31, 2024
BRL (R$)
|
Dec. 31, 2023
BRL (R$)
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Equity |
|
R$ 45,258,425,000
|
R$ 41,601,758,000
|
R$ 45,258,425,000
|
R$ 45,258,425,000
|
R$ 41,601,758,000
|
R$ 41,601,758,000
|
R$ 32,415,575,000
|
R$ 44,810,300,000
|
| Income (expenses) of the period |
|
1,961,387,000
|
3,237,351,000
|
R$ 13,321,518,000
|
|
(308,134,000)
|
|
|
|
| % |
|
|
|
100.00%
|
|
|
|
100.00%
|
|
| In the income (expenses) for the period |
|
|
|
R$ (239,671,000)
|
|
(14,842,000)
|
|
|
|
| Goodwill |
|
189,846,000
|
|
189,846,000
|
189,846,000
|
|
|
R$ 225,486,000
|
|
| Total Investments, including Goodwill and Financial Instruments |
|
1,417,377,000
|
|
1,417,377,000
|
1,417,377,000
|
|
|
1,816,923,000
|
|
| Realization of exchange variation on investments abroad |
|
|
|
(15,636,000)
|
|
|
|
|
|
| Impairment loss (reversal of impairment loss) recognised in profit or loss |
|
|
|
88,871,000
|
|
|
|
|
|
| Other Operating Income (Expense) from Disposal of Property, Plant and Equipment and Biological Assets |
|
|
|
272,228,000
|
|
132,693,000
|
|
|
|
| Associate | Foreign countries |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Investments Accounted for Using Equity Method, Excluding Goodwill |
|
55,434,000
|
|
55,434,000
|
55,434,000
|
|
|
125,316,000
|
|
| In the income (expenses) for the period |
|
|
|
R$ (62,334,000)
|
|
(21,865,000)
|
|
|
|
| Ensyn Corporation | Foreign countries |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Participation equity (%) |
|
|
|
24.80%
|
|
|
|
|
|
| Investments Accounted for Using Equity Method, Excluding Goodwill |
|
(5,187,000)
|
|
R$ (5,187,000)
|
(5,187,000)
|
|
|
2,000
|
|
| In the income (expenses) for the period |
|
|
|
(20,213,000)
|
|
(2,289,000)
|
|
|
|
| Spinnova Plc |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Goodwill |
|
189,846,000
|
|
189,846,000
|
189,846,000
|
|
|
225,486,000
|
|
| Impairment loss (reversal of impairment loss) recognised in profit or loss |
|
|
|
R$ (63,634,000)
|
|
|
|
|
|
| Spinnova Plc | Component Of Other Operating Expenses Related To SPA ClosingConditions |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Other Operating Income (Expense) from Disposal of Property, Plant and Equipment and Biological Assets |
R$ (28,679)
|
|
|
|
|
|
|
|
|
| Spinnova Plc | Foreign countries |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Participation equity (%) |
|
|
|
18.76%
|
|
|
|
|
|
| Investments Accounted for Using Equity Method, Excluding Goodwill |
|
52,479,000
|
|
R$ 52,479,000
|
52,479,000
|
|
|
95,254,000
|
|
| In the income (expenses) for the period |
|
|
|
R$ (40,714,000)
|
|
(19,576,000)
|
|
|
|
| Simplifyber, Inc. (Indirect) | Foreign countries |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Participation equity (%) |
|
|
|
13.91%
|
|
|
|
|
|
| Investments Accounted for Using Equity Method, Excluding Goodwill |
|
7,605,000
|
|
R$ 7,605,000
|
7,605,000
|
|
|
30,060,000
|
|
| In the income (expenses) for the period |
|
|
|
R$ (1,407,000)
|
|
|
|
|
|
| Allotrope Energy Ltd [Member] | Foreign countries |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Participation equity (%) |
|
|
|
20.00%
|
|
|
|
|
|
| Investments Accounted for Using Equity Method, Excluding Goodwill |
|
537,000
|
|
R$ 537,000
|
537,000
|
|
|
|
|
| Joint ventures |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Investments Accounted for Using Equity Method, Excluding Goodwill |
|
209,756,000
|
|
209,756,000
|
209,756,000
|
|
|
328,055,000
|
|
| In the income (expenses) for the period |
|
|
|
R$ (113,703,000)
|
|
7,023,000
|
|
|
|
| Biomas | Country of domicile |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Participation equity (%) |
|
|
|
16.66%
|
|
|
|
|
|
| Investments Accounted for Using Equity Method, Excluding Goodwill |
|
5,802,000
|
|
R$ 5,802,000
|
5,802,000
|
|
|
2,923,000
|
|
| In the income (expenses) for the period |
|
|
|
R$ (4,618,000)
|
|
(3,431,000)
|
|
|
|
| Ibema Companhia Brasileira de Papel | Country of domicile |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Participation equity (%) |
|
|
|
49.90%
|
|
|
|
|
|
| Investments Accounted for Using Equity Method, Excluding Goodwill |
|
198,476,000
|
|
R$ 198,476,000
|
198,476,000
|
|
|
193,901,000
|
|
| In the income (expenses) for the period |
|
|
|
R$ 13,410,000
|
|
27,904,000
|
|
|
|
| F&E Technologies LLC | Foreign countries |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Participation equity (%) |
|
|
|
50.00%
|
|
|
|
|
|
| Investments Accounted for Using Equity Method, Excluding Goodwill |
|
5,478,000
|
|
R$ 5,478,000
|
5,478,000
|
|
|
6,378,000
|
|
| In the income (expenses) for the period |
|
|
|
|
|
|
|
|
|
| Woodspin Oy |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Share Of Profit Loss Of Investments Accounted For Using Equity Method |
|
|
|
R$ (117,848,000)
|
|
|
|
|
|
| Woodspin Oy | Foreign countries |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Participation equity (%) |
|
|
|
50.00%
|
|
|
|
|
|
| Investments Accounted for Using Equity Method, Excluding Goodwill |
|
|
|
|
|
|
|
124,853,000
|
|
| In the income (expenses) for the period |
|
|
|
(122,495,000)
|
|
(17,450,000)
|
|
|
|
| Total other investments evaluated at fair value |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| In the income (expenses) for the period |
|
|
|
|
|
|
|
|
|
| Non-current financial assets at fair value through other comprehensive income |
|
962,341,000
|
|
R$ 962,341,000
|
962,341,000
|
|
|
1,138,066,000
|
|
| Bem Agro Integração e Desenvolvimento S.A. (Indirect) |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| % |
|
|
|
5.82%
|
|
|
|
|
|
| Bem Agro Integração e Desenvolvimento S.A. (Indirect) | Country of domicile |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Non-current financial assets at fair value through other comprehensive income |
|
3,461,000
|
|
R$ 3,461,000
|
3,461,000
|
|
|
4,026,000
|
|
| Celluforce Inc. (Direct) |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| % |
|
|
|
8.28%
|
|
|
|
|
|
| Celluforce Inc. (Direct) | Foreign countries |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Non-current financial assets at fair value through other comprehensive income |
|
24,681,000
|
|
R$ 24,681,000
|
24,681,000
|
|
|
27,823,000
|
|
| Nfinite Nanotechnology Inc. (Indirect) |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| % |
|
|
|
4.90%
|
|
|
|
|
|
| Nfinite Nanotechnology Inc. (Indirect) | Foreign countries |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Non-current financial assets at fair value through other comprehensive income |
|
5,452,000
|
|
R$ 5,452,000
|
5,452,000
|
|
|
6,347,000
|
|
| Lenzing Aktiengesellschaft (Indirect) |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| % |
|
|
|
15.00%
|
|
|
|
|
|
| Lenzing Aktiengesellschaft (Indirect) | Foreign countries |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Non-current financial assets at fair value through other comprehensive income |
|
928,747,000
|
|
R$ 928,747,000
|
928,747,000
|
|
|
1,099,870,000
|
|
| Total Goodwill |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Goodwill |
|
189,846,000
|
|
189,846,000
|
189,846,000
|
|
|
R$ 225,486,000
|
|
| Impairment loss (reversal of impairment loss) recognised in profit or loss |
|
|
|
(63,634,000)
|
|
|
|
|
|
| Ensyn Corporation |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Equity |
|
(20,917,000)
|
|
(20,917,000)
|
(20,917,000)
|
|
|
|
|
| Income (expenses) of the period |
|
|
|
(76,085,000)
|
|
|
|
|
|
| Spinnova Plc |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Equity |
|
279,740,000
|
|
279,740,000
|
R$ 279,740,000
|
|
|
|
|
| Income (expenses) of the period |
|
|
|
(217,242,000)
|
|
|
|
|
|
| NASDAQ, Nordic Growth Market, Average Share Price | € / shares |
|
|
|
|
R$ 0.61
|
|
R$ 0.95
|
|
|
| Biomas | Country of domicile |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Equity |
|
34,828,000
|
|
34,828,000
|
R$ 34,828,000
|
|
|
|
|
| Income (expenses) of the period |
|
|
|
(29,371,000)
|
|
|
|
|
|
| Ibema Companhia Brasileira de Papel | Country of domicile |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Equity |
|
397,748,000
|
|
397,748,000
|
397,748,000
|
|
|
|
|
| Income (expenses) of the period |
|
|
|
26,873,000
|
|
|
|
|
|
| F&E Technologies LLC | Foreign countries |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Equity |
|
10,956,000
|
|
10,956,000
|
10,956,000
|
|
|
|
|
| Income (expenses) of the period |
|
|
|
|
|
|
|
|
|
| Woodspin Oy | Foreign countries |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Equity |
|
234,894,000
|
|
234,894,000
|
234,894,000
|
|
|
|
|
| Income (expenses) of the period |
|
|
|
(26,427,000)
|
|
|
|
|
|
| Simplifyber, Inc. (Indirect) |
|
|
|
|
|
|
|
|
|
| Disclosure of joint ventures [line items] |
|
|
|
|
|
|
|
|
|
| Equity |
|
R$ 54,672,000
|
|
54,672,000
|
R$ 54,672,000
|
|
|
|
|
| Income (expenses) of the period |
|
|
|
R$ (10,115,000)
|
|
|
|
|
|